Trials and Noteworthy Treatments

News Stories

(Relevance) Question - click to see the response!
Displaying 1 to 26 of 66
Click HERE for Next 25 articles!

(Relevance) Page Title - click title to go to the page!

•   (0.8511)   Immunology and immunotherapy in neurosurgical disease.
  
  
•   (0.8510)   NewsRx Announces New Publisher, Editor-In-Chief, Key Staff (Internet Wire)
  ...Formerly, she was with the University of North Carolina School of Medicine, Texas Children`s Hospital, and the University of Texas M.D. Anderson Cancer Center.......NewsRx.net serial titles are monthly, quarterly and annual reports on: AIDS and HIV, AIDS and HIV Adverse Drug Effects, AIDS and HIV Animal Models, AIDS and HIV Blood Safety, AIDS and HIV Cancer, AIDS and HIV Co-infection, AIDS and HIV Cytomegalovirus, AIDS and HIV Depression, AIDS and HIV Dermatology, AIDS and HIV Drug Resistance, AIDS and HIV Funding, AIDS and HIV Genetic, AIDS and HIV Human Papillomavirus, AIDS and HIV Mycobacterium Avium, AIDS and HIV Pathogenesis, AIDS and HIV Pediatric, AIDS and HIV Prophylaxis, AIDS and HIV Public Health, AIDS and HIV Testing, AIDS and HIV Transmission, AIDS and HIV Tuberculosis, AIDS and HIV Vertical Transmission, AIDS and HIV Viral Load, AZT, Abciximab, Abdominal, Abortion, Abortion Issues, Ace Inhibitor, Acetaminophen, Acid Reflux, Acupuncture, Acute Hepatitis, Acute Myocardial Infarction, Addiction Medicine, Adenoviral Vector, Adenovirus, Adiposity, Adjuvant, Adolescent Health, Adoptive Immunotherapy, Adrenergic, Adverse Drug Effects, Age-Related Macular Degeneration, Aging, Alcoholism, Allergic Rhinitis, Allergy Medicine, Allograft, Alzheimer`s Disease, Amyloid, Analgesia, Anemia, Anesthesia, Angina, Angiogenesis, Angiogenic, Angiology, Angiology Prognosis, Angioplasty, Angiotensin, Animal Models, Animal Studies, Anorexia, Anthrax, Antibiotic Resistance, Antidepressant, Antifungal, Antihistamine, Antimicrobial Resistance, Antioxidant, Antisense Technology, Antiviral, Anxiety Disorder, Apolipoprotein, Apoptosis, Arthritis Risk Factors, Arthritis Therapy, Asthma, Atherosclerosis, Atrial Fibrillation, Attention Deficit Hyperactivity Disorder, Autism, Autoimmune Disease, Autoimmunity, Autologous, Back Pain, Bacterial Meningitis, Bacteriology, Behavioral Medicine, Bile, Biliary, Biocompatibility, Bi
  
  
•   (0.8351)   OncoMune Scientists Announce Breakthrough Proof of Concept Finding at International Immunology Symposium
  
  
•   (0.8347)   Neurocrine Biosciences Announces the Appointment Of Lawrence Steinman, M.D. to Its Board of Directors (PR Newswire)
  ..., immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes....
  - Jan 31 12:10 PM ET
  
  
•   (0.7967)   Sangamo BioSciences and City of Hope Announce License Agreement and Research Collaboration to Develop Treatment for Brain Cancer
  
  
•   (0.7967)   Oral Desensitization Prevents Recurrent Imatinib (Gleevec) Rash
  
  
•   (0.7967)   Study: Compound suppresses cancer growth
  
  
•   (0.7967)   WHO TO SEE FOR STAR TREATMENT (New York Post)
  ...Weill Cornell Medical Center; 212-746-6141 Jerome Posner Neuro-oncology and brain tumors; Memorial Sloan Kettering; 212-639-7047 Michael Swerdlow Myasthenia gravis;...
  - Mar 25 2:39 AM ET
  
  
•   (0.7967)   Loco-regional radioimmunotherapy of malignant glioma by means of a humanised antibody hR3 (raised against epidermal growth factor receptors) labelled with Y-90
  
  
•   (0.7967)   Appointments to AEterna`s Scientific Advisory Board - Company intensifies focus on clinical research in oncology (Canada NewsWire)
  ...he completed training in hematology, medical oncology and tumor immunology at the Dana-......His research is aimed mainly at molecular biology of brain tumors, including use of gene therapy....
  - Feb 23 7:30 AM ET
  
  
•   (0.7967)   Appointments to AEterna`s Scientific Advisory Board - Company Intensifies Focus on Clinical Research in Oncology (PR Newswire)
  ...he completed training in hematology, medical oncology and tumor immunology at the Dana-......His research is aimed mainly at molecular biology of brain tumors, including use of gene therapy....
  - Feb 23 7:31 AM ET
  
  
•   (0.7967)   Appointments to AEterna`s Scientific Advisory Board - Company intensifies focus on clinical research in oncology (Canada NewsWire)
  ...he completed training in hematology, medical oncology and tumor immunology at the Dana-......His research is aimed mainly at molecular biology of brain tumors, including use of gene therapy....
  - Feb 23 7:30 AM ET
  
  
•   (0.7967)   Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study
  
  
•   (0.7967)   New technology blocks gene to increase immune response against deadly brain tumor cells
  
  
•   (0.7967)   Panacea Pharmaceuticals, Inc. Announces Members of Scientific Advisory Board (Business Wire)
  Panacea Pharmaceuticals, Inc. is pleased to announce the initial members of its Scientific Advisory Board.
  - Dec 05 2:47 PM ET
  
  
•   (0.7961)   Cancer Vaccine Treatments Promising for Prostate and Brain Tumors
  
  
•   (0.7742)   Quantum Rod System May Safely `Sneak` Drugs, Diagnostics into Brain System also can serve as "test kit" for evaluating new transporter molecules
  
  
•   (0.7742)   Cancer drug from Cuba undergoes rare U.S. trial (for brainstem glioma as well as GBMs)
  
  
•   (0.7742)   *** Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms
  
  
•   (0.7742)   Heroes of Hope Race and Kids Fun Run to Benefit Brain Tumor Research
  
  
•   (0.7742)   Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib.
  
  
•   (0.7742)   ZFN Modified Cells Show Glioblastoma Killing in the Presence of Dexamethasone in Mouse Tumor Model
  
  
•   (0.7742)   In Vivo Vaccination With Tumor Cell Lysate Plus CpG Oligodeoxynucleotides Eradicates Murine Glioblastoma.
  
  
•   (0.7742)   Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics.
  
  
•   (0.7742)   YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
  
  

Frequently Asked Questions